Good news for the eczema community! Did you know there are currently more than 80 new treatments in development for the treatment of atopic dermatitis (AD)?
New developments include oral, injectable, and topical treatments, and even experimental treatments like fecal transplantation (wait, what?!). There has never been a time of such growth and exploration to help AD sufferers.
For decades, the treatment of AD was limited to only a handful of options, however in recent years, the eczema community has seen a number of research breakthroughs that have led to new and targeted treatment options.
During a recent webinar, ESC had the opportunity to discuss the latest in AD treatment advances with Winnipeg-based dermatologist Dr. Marni Wiseman, MD, FRCPC. She shared her enthusiasm for the progress being made in the development of effective new therapies.
“The treatment of AD has changed a tremendous amount, and the future for AD treatment is incredibly bright. There are so many new treatments currently under development, and the next 10, 20, 30 years look very hopeful for AD sufferers.”
The treatment pathway for AD is long, from topical medications all the way to systemic medications, which may be used when AD is more severe or unresponsive to the topical medications. Given the research community’s increased focus on the development of targeted treatments, the future is indeed bright.
Eczema Society of Canada (ESC) thanks Dr. Marni Wiseman, MD, FRCPC, for sharing her expertise during ESC’s March 2022 Life with Eczema virtual event series and on this content. Funding for the Life with Eczema Winter 2022 event series was generously provided by Pfizer Canada and Sanofi Genzyme, a division of sanofi-aventis Canada Inc.
Disclaimer: Information provided in this resource does not constitute medical advice and is not intended to be used as a diagnostic tool. The information is up-to-date at time of publication. All medications, interventions, and treatment plans have risks and benefits, and it is important that individuals discuss their or their child’s specific health care needs with a qualified health care professional.
March 2022
